Skip to Main Content

Stock in Foghorn Therapeutics Inc. was up about 14 percent Friday morning in its first day of trading on the Nasdaq exchange, after the Cambridge biotech startup raised $120 million in its initial public offering.

The biotech on Thursday said it would offer 7.5 million shares at $16 apiece, the midpoint of its expected range of $15 to $17. The stock is trading under the ticker FHTX.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!